Duk JM - Search Results

1

Cancer of the uterine cervix: sensitivity and specificity of serum squamous cell carcinoma antigen determinations.

Duk JM, de Bruijn HW, Groenier KH, Hollema H, ten Hoor KA, Krans M, Aalders JG. Duk JM, et al. Gynecol Oncol. 1990 Nov;39(2):186-94. doi: 10.1016/0090-8258(90)90430-s. Gynecol Oncol. 1990. PMID: 2227594

2

Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer.

Reesink-Peters N, van der Velden J, Ten Hoor KA, Boezen HM, de Vries EG, Schilthuis MS, Mourits MJ, Nijman HW, Aalders JG, Hollema H, Pras E, Duk JM, van der Zee AG. Reesink-Peters N, et al. Among authors: duk jm. J Clin Oncol. 2005 Mar 1;23(7):1455-62. doi: 10.1200/JCO.2005.02.123. J Clin Oncol. 2005. PMID: 15735121

3

The effect of abdominal surgery on the serum concentration of the tumour-associated antigen CA 125.

van der Zee AG, Duk JM, Aalders JG, Boontje AH, ten Hoor KA, de Bruijn HW. van der Zee AG, et al. Among authors: duk jm. Br J Obstet Gynaecol. 1990 Oct;97(10):934-8. doi: 10.1111/j.1471-0528.1990.tb02450.x. Br J Obstet Gynaecol. 1990. PMID: 2223686

4

Transformation of histological tumor type of the cervix expressed in different tumor markers in the serum.

Aalders JG, de Bruijn HW, Oosterhuis JW, Duk JM. Aalders JG, et al. Among authors: duk jm. Gynecol Oncol. 1990 Jan;36(1):110-2. doi: 10.1016/0090-8258(90)90119-6. Gynecol Oncol. 1990. PMID: 2295441 No abstract available.

5

Adenocarcinoma of the uterine cervix. Prognostic significance of pretreatment serum CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen levels in relation to clinical and histopathologic tumor characteristics.

Duk JM, De Bruijn HW, Groenier KH, Fleuren GJ, Aalders JG. Duk JM, et al. Cancer. 1990 Apr 15;65(8):1830-7. doi: 10.1002/1097-0142(19900415)65:8<1830::aid-cncr2820650828>3.0.co;2-s. Cancer. 1990. PMID: 2317761

6

Serum CA 125 levels in patients with a provisional diagnosis of pelvic inflammatory disease. Clinical and theoretical implications.

Duk JM, Kauer FM, Fleuren GJ, de Bruijn HW. Duk JM, et al. Acta Obstet Gynecol Scand. 1989;68(7):637-41. doi: 10.3109/00016348909013284. Acta Obstet Gynecol Scand. 1989. PMID: 2631530

7

Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix.

Duk JM, Aalders JG, Fleuren GJ, Krans M, De Bruijn HW. Duk JM, et al. Obstet Gynecol. 1989 Apr;73(4):661-8. Obstet Gynecol. 1989. PMID: 2648225

8

Elevated levels of squamous cell carcinoma antigen in patients with a benign disease of the skin.

Duk JM, van Voorst Vader PC, ten Hoor KA, Hollema H, Doeglas HM, de Bruijn HW. Duk JM, et al. Cancer. 1989 Oct 15;64(8):1652-6. doi: 10.1002/1097-0142(19891015)64:8<1652::aid-cncr2820640816>3.0.co;2-m. Cancer. 1989. PMID: 2790678

9

Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma.

Duk JM, Groenier KH, de Bruijn HW, Hollema H, ten Hoor KA, van der Zee AG, Aalders JG. Duk JM, et al. J Clin Oncol. 1996 Jan;14(1):111-8. doi: 10.1200/JCO.1996.14.1.111. J Clin Oncol. 1996. PMID: 8558185

10

The clinical value of squamous cell carcinoma antigen in cancer of the uterine cervix.

de Bruijn HW, Duk JM, van der Zee AG, Pras E, Willemse PH, Boonstra H, Hollema H, Mourits MJ, de Vries EG, Aalders JG. de Bruijn HW, et al. Among authors: duk jm. Tumour Biol. 1998;19(6):505-16. doi: 10.1159/000030044. Tumour Biol. 1998. PMID: 9817980

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters